Financials

This section of the Anika Therapeutics, Inc. InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing. 

Please note:  All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes.  COMPANY NAME assumes no responsibility for the accuracy of this data and provides it for informational purposes only.

NASDAQANIK
Beta0.78
Shares Outstanding14.6M
Average Volume (10 days)624.1K
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)($1.52)
Sales (TTM)$3.03
Book Value (MRQ)$18.73
Cash Flow (TTM)($0.60)
Cash (MRQ)$6.93

Analyst Views

Current Mean RecommendationBuy
Strong Buy1
 
Buy0
 
Hold1
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Richard Stephen
Director
6,500
Acquire
Jun 14, 2023
Vogt Susan
Director
6,500
Acquire
Jun 14, 2023
Thompson Jeffery
Director
6,500
Acquire
Jun 14, 2023
Larsen Glenn
Director
6,500
Acquire
Jun 14, 2023
Conley Sheryl
Director
6,500
Acquire
Jun 14, 2023

Recent SEC Filings

8-K
Company Events
Sep 21, 2023
SC 13D/A
SC 13D/A
Sep 11, 2023
SC 13D
SC 13D
Aug 17, 2023
4
Insider Buy/Sell
Aug 11, 2023
10-Q
Quarterly Financials
Aug 8, 2023
Currency in USD.
Quote data delayed by at least 15 minutes.
Earnings and Analyst data provided by Zacks.
Insiders data provided by Morningstar.
To Top